Back to Directory
Last Updated: 09/06/2026
Wobble Genomics
Edinburgh
Founded 2021
Long-read RNA sequencing platform for cancer biomarker discovery and diagnostics
Wobble Genomics is a Scottish biotechnology company developing long-read RNA sequencing technologies for biomarker discovery and cancer diagnostics.
Its core platform combines a biochemical method to enrich rare and low-abundance full-length RNA transcripts, with a bioinformatics pipeline for novel transcript identification.
The company is building a clinical diagnostic platform for breast cancer detection using cell-free RNA liquid biopsy, with broader applications in oncology drug discovery and disease monitoring.